OncoTargets and Therapy · 2019 · 38 citations · 22 references
MedicineOncologyRadiation OncologyGastrointestinal OncologyHepatologyRadionuclide TherapyBiliary InterventionsBiliary Tract CancerHepatobiliary CancerLiver DiseaseRadiation TherapyResponse AssessmentComplete Response AssessmentIntrahepatic Cholangiocarcinoma SurgeryLiver Tumor TherapyMicrospheresPartial Response AssessmentTherapeutic Efficacy AssessmentTransarterial RadioembolizationYttrium-90 Radioembolization
Purpose: The aim of this pooled analysis was to evaluate the clinical efficacy and safety of transarterial radioembolization (TARE) with yttrium-90 ( 90 Y) microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma (ICC). Methods: We searched the Cochrane Library, Embase, PubMed, SCI with the English language from inception to October 2018. A pooled analysis was conducted using Stata software. Results: There were 16 eligible studies included in this pooled analysis. The pooled median overall survival (OS) from 12 studies was 14.3 (95% CI: 11.9–17.1) months. Based on Response Evaluation Criteria in Solid Tumors (RECIST), no complete response was reported, and the median of partial response, stable disease and progressive disease were 11.5% (range: 4.8–35.3%), 61.5% (range: 42.9–81.3%) and 22.7% (range: 12.5–52.4%) respectively. The pooled disease control rate (DCR) from nine studies was 77.2% (95% CI: 70.2–84.2%). According to the type of microspheres, subgroup analysis was performed, the median OS in the glass microspheres group was 14.0 (95% CI: 9.1–21.4) months, and 14.3 (95% CI: 11.5–17.8) months in the resin microspheres group. The DCR was 77.3% (95% CI: 63.5–91.1%) and 77.4% (95% CI: 66.8–87.9%) in the glass and resin microspheres groups respectively. Most of the side effects reported in the included studies were mild and did not require intervention. Conclusion: TARE with 90 Y microspheres is safe and effective for patients with unresectable ICC with acceptable side effects. And it seems that the type of microsphere has no influence on therapeutic efficacy. Keywords: transarterial radioembolization, yttrium-90 microspheres, intrahepatic cholangiocarcinoma, pooled analysis
22
Sara H. Downs, Nicholas Black · Journal of Epidemiology & Community Health · 1998 · 8.3K citations · Full text
Ralf-T. Hoffmann, Philipp M. Paprottka, Agnes Schön et al. · CardioVascular and Interventional Radiology · 2011 · 226 citations
Shoaib Rafi, S.M. Piduru, Bassel F. El‐Rayes et al. · CardioVascular and Interventional Radiology · 2012 · 159 citations